Chelsea AGREE record £115m transfer deal for Enzo Fernandez as Benfica star 'undergoes medical in Lisbon' | The Sun

CHELSEA have finally agreed a payment schedule with Benfica to sign midfielder Enzo Fernandez.

The Blues are set to sign the 22-year-old in time ahead of tonight's transfer deadline.

SunSport reported yesterday that the Blues were planning a final £115millon push for Fernandez after having a number of bids rejected.

The move is set to be a British record, surpassing the £100m Manchester City paid to sign Jack Grealish in 2021.

Sky Sports claim, via Portuguese broadcaster SIC, that Fernandez is undergoing a medical in Lisbon before the move is made official.

Teams in England have until 11pm on Tuesday evening to make any deadline day additions.

Read More In Football

Chelsea’s Enzo Fernandez BRITISH-RECORD fee agreed, Jorginho joining Arsenal

Best no deposit bonuses :Top no deposit casinos for February 2023

Fernandez only joined Benfica in July from Argentinian club River Plate.

He has made 17 appearances for the club, and also starred for Argentina as they won the World Cup in Qatar last month.

Chelsea have already signed SEVEN players in January, coming to a total spend of around £220m.

Joao Felix, Benoit Badiashile, David Datro Fofana, Mykhailo Mudryk, Andrey Santos, Noni Madueke and Malo Gusto have been recruited, with the latter returning on loan to Lyon until the end of the season.

Most read in Football


Enzo Fernandez set for Chelsea MEDICAL, Jorginho pictured in Arsenal top


Latest reaction from FA Cup fifth round draw with EIGHT big ties drawn


Man Utd 'considering shock last-minute Raphinha swoop but Chelsea also keen'


Liverpool 'plot swoop for Chelsea star Kante as Klopp looks to strengthen midfield'

More to follow…

THIS IS A DEVELOPING STORY…The Sun is your go to destination for the best football, boxing and MMA news, real-life stories, jaw-dropping pictures and must-see video.Like us on Facebook at and follow us from our main Twitter account at @TheSunFootball.

Source: Read Full Article